RESTON, Va. -- The potential of molecular imaging and therapy and the power of nuclear medicineand their impact on patient carewill be explored as more than 4,000 doctors, technologists, scientists and pharmacists from around the world attend SNMs 54th Annual Meeting June 26 in Washington, D.C. SNMan international, multidisciplinary society of more than 16,000 molecular imaging and nuclear medicine professionals in 78 countriesannually showcases research that promises to revolutionize health care.
"SNM has embarked on a mission to improve health care by advancing molecular imaging and therapy, and our program features an increased presence of related research," said SNM President Martin P. Sandler. "Molecular imagingthe use of state-of-the-art imaging technologies (such as PET, SPECT, MRI and others) to "photograph" biological targets or pathways in the bodyand its therapy value will be at the forefront of personalized medicine, eventually providing patient-specific information that allows tailored treatment of disease," he added.
"Nearly 2,000 scientific and technologist studies will be presented during this meeting, offering a look at molecular imaging and nuclear medicine research leading to improvements in the diagnosis and treatment of life-threatening cancer, heart disease and brain disorders," said Scientific Program Committee Chair Frederic H. Fahey. "A new feature this year is the InfoSNM program, which will allow attendees to participate in interactive computer presentations and educational offerings on the novel applications of computers and information science in molecular imaging and nuclear medicine," explained Fahey. Also new will be the Molecular Imaging Gateway, an area devoted specifically to this exciting field sponsored by the societys Molecular Imaging Center of Excellence.
"As molecular imaging becomes a significant force in clinical practice, SNM Technologist Section members will assume an expanded role in med
Contact: Maryann Verrillo
Society of Nuclear Medicine